Nikko Asset Management Americas, Inc. Syros Pharmaceuticals, Inc. Transaction History

Nikko Asset Management Americas, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$5.01 - $7.48 $25.3 Million - $37.7 Million	-5,042,009 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$7.19 - $14.95 $4.75 Million - $9.87 Million	660,017 Added 15.06%	5,042,009 $37.7 Million
Q4 2020 Feb 11, 2021	BUY	$6.66 - $14.66 $1.33 Million - $2.93 Million	199,646 Added 4.77%	4,381,992 $47.5 Million
Q3 2020 Nov 02, 2020	SELL	$8.69 - $14.47 $4.62 Million - $7.69 Million	-531,248 Reduced 11.27%	4,182,346 $36.3 Million
Q2 2020 Aug 07, 2020	SELL	$5.21 - $11.03 $1.1 Million - $2.33 Million	-211,612 Reduced 4.3%	4,713,594 $38.9 Million
Q1 2020 Apr 30, 2020	SELL	$4.46 - $9.2 $220,573 - $454,995	-49,456 Reduced 0.99%	4,925,206 $29.2 Million
Q4 2019 Feb 06, 2020	BUY	$4.52 - $10.1 $1.54 Million - $3.44 Million	340,889 Added 7.36%	4,974,662 $34.4 Million
Q3 2019 Oct 29, 2019	BUY	$7.14 - $11.65 $11.8 Million - $19.2 Million	1,646,010 Added 55.09%	4,633,773 $48.1 Million
Q2 2019 Jul 29, 2019	BUY	$5.5 - $9.75 $12.7 Million - $22.5 Million	2,303,288 Added 336.5%	2,987,763 $27.7 Million
Q1 2019 Apr 30, 2019	BUY	$5.51 - $9.59 $3.76 Million - $6.54 Million	682,454 Added 33768.13%	684,475 $6.26 Million
Q4 2018 Feb 08, 2019	SELL	$5.55 - $11.34 $160 - $328	-29 Reduced 1.41%	2,021 $11,000
Q3 2018 Oct 15, 2018	BUY	$9.74 - $12.92 $19,967 - $26,486	2,050 New	2,050 $25,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.